ExodusPoint Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
193,494
+174,326
| +909% | +$1.99M | 0.02% | 662 |
|
|
2025
Q1 | $228K | Sell |
19,168
-66,494
| -78% | -$791K | ﹤0.01% | 1218 |
|
|
2024
Q4 | $1.61M | Buy |
85,662
+51,049
| +147% | +$962K | 0.01% | 726 |
|
|
2024
Q3 | $778K | Sell |
34,613
-285,939
| -89% | -$6.43M | ﹤0.01% | 989 |
|
|
2024
Q2 | $6.69M | Buy |
320,552
+154,949
| +94% | +$3.23M | 0.05% | 286 |
|
|
2024
Q1 | $2.43M | Sell |
165,603
-132,166
| -44% | -$1.94M | 0.02% | 528 |
|
|
2023
Q4 | $3.07M | Buy |
297,769
+247,621
| +494% | +$2.56M | 0.02% | 416 |
|
|
2023
Q3 | $394K | Buy |
50,148
+8,430
| +20% | +$66.2K | ﹤0.01% | 1276 |
|
|
2023
Q2 | $417K | Buy |
+41,718
| New | +$417K | ﹤0.01% | 1332 |
|
|
2022
Q4 | – | Sell |
-25,954
| Closed | -$338K | – | 1904 |
|
|
2022
Q3 | $338K | Buy |
+25,954
| New | +$338K | ﹤0.01% | 1459 |
|
|
2022
Q2 | – | Sell |
-15,034
| Closed | -$211K | – | 2214 |
|
|
2022
Q1 | $211K | Buy |
+15,034
| New | +$211K | ﹤0.01% | 1828 |
|
|
2021
Q4 | – | Sell |
-10,747
| Closed | -$322K | – | 2406 |
|
|
2021
Q3 | $322K | Buy |
+10,747
| New | +$322K | ﹤0.01% | 1542 |
|